China outlines adjuvant drug list

China’s National Health Commission announced plans to create a national adjuvant drug list and guidelines that could limit the sales of those drugs.

A notice released last week called for the establishment of a system to monitor and evaluate clinical adjuvant drug use based on spending, the amount of drugs prescribed and other criteria. Physicians will be required to limit the indications treated with adjuvant drugs in accordance with the drugs’ prescribing instructions, without alteration of dosage or treatment course...